Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person Heparan sulfate (HS) is involved in regulating various body ...
| Class:Id | Summation:3702138 |
|---|---|
| _displayName | Heparan sulfate (HS) is involved in regulating various body ... |
| _timestamp | 2014-07-10 08:48:26 |
| created | [InstanceEdit:3702140] Jassal, B, 2013-06-13 |
| modified | [InstanceEdit:3702179] Jassal, B, 2013-06-13 [InstanceEdit:3730939] Jassal, B, 2013-06-17 [InstanceEdit:5607074] Jassal, Bijay, 2014-07-10 |
| text | Heparan sulfate (HS) is involved in regulating various body functions functions during development, homeostasis and pathology including blood clotting, angiogenesis and metastasis of cancer cells. Exostosin 1 and 2 (EXT1 and 2) glycosyltransferases are required to form HS. They are able to transfer N-acetylglucosamine (GlcNAc) and glucuronate (GlcA) to HS during its synthesis. The functional form of these enzymes appears to be a complex of the two located on the Golgi membrane. Defects in either EXT1 or EXT2 can cause hereditary multiple exostoses 1 (Petersen 1989) and 2 (McGaughran et al. 1995) respectively (MIM:133700 and MIM:133701), autosomal dominant disorders characterized by multiple projections of bone capped by cartilage resulting in deformed legs, forearms and hands. Trichorhinophalangeal syndrome, type II (TRPS2 aka Langer-Giedion syndrome, LGS) is a disorder that combines the clinical features of trichorhinophalangeal syndrome type I (TRPS1, MIM:190350) and multiple exostoses type I, caused by mutations in the TRPS1 and EXT1 genes, respectively (Langer et al. 1984, Ludecke et al. 1995). Defects in EXT1 may also be responsible for chondrosarcoma (CHDS; MIM:215300) (Schajowicz & Bessone 1967, Hecht et al. 1995). |
| (summation) | [Pathway:3656253] Defective EXT1 causes exostoses 1, TRPS2 and CHDS [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by Heparan sulfate (HS) is involved in regulating various body ... (3702138)
